Many news outlets reported on the apparent success of an experimental malaria vaccine that was administered to infants.
A clinical trial in Mozambique of 214 infants aged 10 to 18 weeks found the vaccine was safe and reduced new infections by 65 percent over a three-month period after treatment. Clinical illness was cut by 35 percent over six months.
A new vaccine could be commercially available in 2012, according to Reuters.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment